Head to Head Review: TTM Technologies (NASDAQ:TTMI) versus 908 Devices (NASDAQ:MASS)

TTM Technologies (NASDAQ:TTMI) and 908 Devices (NASDAQ:MASS) are both technology companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, earnings, risk and dividends.

Valuation and Earnings

This table compares TTM Technologies and 908 Devices”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TTM Technologies	$2.91 billion	4.39	$177.45 million	$2.22	54.51
908 Devices	$56.20 million	8.86	$19.49 million	($0.95)	-12.68

TTM Technologies has higher revenue and earnings than 908 Devices. 908 Devices is trading at a lower price-to-earnings ratio than TTM Technologies, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares TTM Technologies and 908 Devices’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
TTM Technologies	7.01%	15.67%	7.11%
908 Devices	-56.96%	-12.54%	-8.87%

Risk & Volatility

TTM Technologies has a beta of 2.14, indicating that its stock price is 114% more volatile than the S&P 500. Comparatively, 908 Devices has a beta of 0.63, indicating that its stock price is 37% less volatile than the S&P 500.

Institutional and Insider Ownership

95.8% of TTM Technologies shares are owned by institutional investors. Comparatively, 88.1% of 908 Devices shares are owned by institutional investors. 1.3% of TTM Technologies shares are owned by company insiders. Comparatively, 28.2% of 908 Devices shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Analyst Recommendations

This is a summary of current ratings and target prices for TTM Technologies and 908 Devices, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TTM Technologies	0	2	4	0	2.67
908 Devices	1	0	3	0	2.50

TTM Technologies presently has a consensus target price of $203.00, suggesting a potential upside of 67.75%. 908 Devices has a consensus target price of $12.83, suggesting a potential upside of 6.50%. Given TTM Technologies’ stronger consensus rating and higher probable upside, equities analysts clearly believe TTM Technologies is more favorable than 908 Devices.

Summary

TTM Technologies beats 908 Devices on 12 of the 14 factors compared between the two stocks.

About TTM Technologies

TTM Technologies, Inc., together with its subsidiaries, manufactures and sells mission systems, radio frequency (RF) components and RF microwave/microelectronic assemblies, and printed circuit boards (PCB) worldwide. The company operates in two segments, PCB and RF&S Components. It offers range of engineered systems, RF and microwave assemblies, HDI PCBs, flexible PCBs, rigid-flex PCBs, custom assemblies and system integration, IC substrates, passive RF components, advanced ceramic RF components, hi-reliability multi-chip modules, beamforming and switching networks, PCB products, RF components, and backplane/custom assembly solutions, including conventional PCBs. It also provides advanced ceramic RF components including standard and etched thick-film ceramic substrates; and hi-reliability multi-chip modules. In addition, the company offers radar systems including maritime surveillance and weather avoidance radar systems, surveillance products, communication systems, RF assembly and test services, and passive RF components. Further, the company provides custom designed application specific integrated circuits, high density interconnect, IC substrates, flexible and rigid flex PCBs, and custom assemblies including backplane and mid-plane assemblies, flexible and rigid-flex assemblies, and RF assemblies, as well as conventional PCBs, such as single-sided, double-sided, and multi-layer boards. Additionally, it offers quick turnaround services, which includes prototype production and ramp-to-volume production, and thermal management. The company serves original equipment manufacturers and electronic manufacturing services providers, original design manufacturers, distributors, and government agencies; and aerospace and defense, data center computing, automotive, medical, industrial, and instrumentation, as well as networking applications. TTM Technologies, Inc. was incorporated in 1978 and is headquartered in Santa Ana, California.

About 908 Devices

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.